Three comparable groups of surgical patients were given nefopam 0.2 mg kg" 1 or 0.4 mg kg" 1 or morphine 0.15 mg kg" 1 for pain relief after operation. Nefopam 0.4mgkg~1 was equi-analgesic with morphine 0.15 mg kg" 1 and produced no obvious cardiovascular or respiratory side-effects.
Nefopam hydrochloride is a new non-narcotic analgesic agent unrelated pharmacologically to any known analgesic drug. Its analgesic effects have been demonstrated by Cohen (1974) , Gassel and others (1976) and Workmon and Winter (1974) . Gasser and Belville (1975) found no evidence of respiratory depression when nefopam was administered parenterally in therapeutic doses. Indeed, it appeared to possess central nervous system stimulant effects (Re, 1975) . Sunshine and Laska (1975) and Beaver and Feise (1977) have shown that nefopam 20 mg is equi-analgesic with morphine 7-12 mg. A doubleblind clinical trial was devised to assess the efficacy of nefopam given parenterally at two doses for pain after operation and to compare it with morphine, to determine the equi-analgesic dose of morphine and nefopam.
PATIENTS AND METHODS
Seventy-six patients of either sex, between the ages of 18 and 70 yr (weight 50-80 kg), were allocated randomly to one of three trial groups. Any patient with medical disease was excluded, as were pregnant or lactating women. Written, informed consent was obtained from each patient before study.
The patients were premedicated with an opiate or a tranquillizing drug, with or without the addition of atropine. Anaesthesia was induced with thiopentone, usually followed by suxamethonium, and maintained with nitrous oxide in oxygen, supplemented with halothane or neuroleptanalgesia (fentanyl or phenoperidine with droperidol). A myoneural blocking drug •f Department of Anaesthesia, University Hospital of Wales, Heath Park, Cardiff.
0007-0912/79/100961-05 $01.00 was given to facilitate artificial ventilation of the lungs.
Each patient was given a single dose of the test analgesic within 24 h of when he or she complained of moderate to severe pain, provided that at least 4 h had elapsed since any previous administration of analgesic.
The doses used were morphine 0.15 mg kg-1 and nefopam 0.2 and 0.4 mg kg-1 . The patient's weight was measured to the nearest 5 kg and the drugs administered in a volume of 0.1 ml/5 kg i.m. The drugs were dispensed in identical ampoules and neither patient nor observer was aware of which drug had been given.
The patients were interviewed throughout by the same observer (G. P.), who recorded the pain as absent, mild, moderate or severe, and asked about any side-effects. Pain relief was assessed before the test dose, at 20, 40 and 60 min after administration, and again after 2, 3, 4, 5 and 6 h. In addition to asking about specific symptoms, the patients were asked on each occasion "How do you feel?" in an attempt to elicit other symptoms. The side-effects were graded as mild, moderate or severe.
Any patient who had inadequate pain relief within 3 h of the test injection received supplementary analgesics and was withdrawn from the trial. If the pain was relieved initially but returned more than 3 h later, the analgesic drug prescribed by the surgical team for use after operation was given, but pain intensity and assessments of relief were taken as being at this level for the remainder of the trial.
Twenty-six patients received morphine sulphate O.lSmgkg-1 , 25 received nefopam hydrochloride 0.2 mg kg-1 and 25 nefopam hydrochloride 0.4 mg kg"
1 . One patient who received morphine on entering the study required further analgesics at 1 h and at 5 h and was withdrawn from the trial. Only the data from the remaining 75 patients were analysed. The patient responses were scored as 0-3, according to the severity of the pain, 0 indicating no pain and 3 groups ranged from 2.36 to 2.56 (table III) , and these indicating severe pain. differences were not statistically significant. The pain The following indices were derived: intensity, pain intensity difference and summated Pain intensity score-the mean value at each assess-pain intensity difference scores are shown in table III.  ment time  The pain intensity and pain intensity difference Sum of pain intensity difference score-the sum of the were consistently greater than those to nefopam pain intensity difference scores weighted according 0.2 mg kg-1 . However, these differences only became to the time intervals between assessments. statistically significant after 2 h. This appeared to result from a shorter duration of action of the nefo-RESULTS p am Thi s was seen also with the larger dose of The groups were comparable in respect of age and nefopam and is reflected in the slightly smaller sum sex (table I) and the operations performed (table II) . of pain intensity differences for nefopam 0.4 mg kg" The mean initial pain intensity scores for the three compared with morphine 0.15 mg kg -1 . The most common side-effect was drowsiness, which occurred in 70% of patients who received morphine, and 68% of those given low-dose nefopam (table IV) . The frequency of drowsiness in patients given the larger dose of nefopam was significantly less
The most striking side-effect of nefopam was sweating, which occurred in 62% of patients. It was usually transient, starting 20-30 min after administration of the drug, and lasting 20-30 min. The frequency of all side-effects was greatest in the group receiving high-dose nefopam; four patients in this group reported sensations of euphoria.
DISCUSSION
The methods employed for assessing pain relief in this study were based on those of Houde, Wallenstein and Rogers (1960) . Apart from three patients who underwent nephrectomy, all the patients in the trial underwent abdominal surgery so that the nature and severity of the pain which followed operation was standardized to some extent (Parkhouse, Lambrechts and Simpson, 1961) . The pain scores for morphine found in this trial agree with those quoted by Sunshine and Laska (1975) and Beaver and Feise (1977) . The larger dose of nefopam produced an analgesia curve similar to that of morphine in terms of onset of action, peak relief of pain and duration of action; statistical analysis was unable to differentiate between the two. The degree of analgesia and duration of action of the smaller dose of nefopam was less than that afforded by the other drug regimes and this difference was statistically significant at all times after 3 h. The results indicate that nefopam 20 mg is therapeutically equivalent to morphine 7.5 mg when the drugs are given i.m. This compares with two previous series in which nefopam 20 mg has been shown to be equianalgesic with morphine 12 mg and 7 mg respectively (Sunshine and Laska, 1975; Beaver and Feise, 1977) .
There was a high frequency of drowsiness, though the larger dose of nefopam produced less, presumably because of the central nervous system stimulant effect of the drug (Re, 1975) . Sweating was the most severe side-effect of nefopam, but this was usually transient. The occurrence of euphoria in a proportion of patients receiving the large dose of nefopam is noteworthy. This drug has been noted to have some anti-depressant effect, although previous studies using an oral preparation which was administered to volunteers over a 90-day period failed to show any evidence of habituation (Klotz, 1974) .
Nefopam hydrochloride appears to be an effective analgesic agent in the treatment of moderate to severe pain after operation, and is free of serious cardiovascular or respiratory side-effects. Nefopam 20 mg was found to be approximately equi-potent with morphine sulphate 7.5 mg.
LE NEFOPAM CONTRE LA DOULEUR POST-OPERATOIRE

RESUME
On a administre a trois groupes comparables d'oper£s du nefopam a raison de 0,2 mg kg" 1 ou de 0,4 mg kg-1 ou encore de la morphine a raison de 0,15 mg kg-1 pour soulager la douleur post-operatoire. Le nefopam a raison de O^mgkg-1 a ete 6qui-analgesique a la morphine administree a raison de 0,15 mg kg-1 et n'a produit aucun effet secondaire respiratoire ou cardiovasculaire evident. 
NEOFAM EN DOLORES POSTOPERATORIOS
SUMARIO
Para aliviar los dolores postoperatorios, se administro a tres grupos de pacientes de cirujia comparables 0,2 mg kg-1 6 O^mgkg-1 de neofam 6 0,15 mg kg" 1 de morfina. Se comprobo que el poder analgesico de 0,4 mg kg-1 de neofam era igual al de 0,15 mg kg" 1 de morfina y que no did lugar a efectos respiratorios o cardiovasculares secundarios obvios.
